ITGA2B and hepatocellular carcinoma: We also found that higher expression of ITGA5, ITGB5 and ITGA2B predicted worse prognosis in HBV-related HCC patients, and patients with lower expression of both ITGA5 and ITGB5 had the best prognosis.